A detailed history of Bank Of Montreal transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 4,119 shares of MEDP stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,119
Previous 4,701 12.38%
Holding current value
$1.39 Million
Previous $1.9 Million 10.69%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$372.0 - $424.34 $216,504 - $246,965
-582 Reduced 12.38%
4,119 $1.7 Million
Q1 2024

May 13, 2024

BUY
$284.87 - $413.31 $210,803 - $305,849
740 Added 18.68%
4,701 $1.9 Million
Q4 2023

Feb 08, 2024

SELL
$227.52 - $312.68 $3.66 Million - $5.03 Million
-16,093 Reduced 80.25%
3,961 $1.21 Million
Q3 2023

Nov 01, 2023

BUY
$233.98 - $281.67 $3.53 Million - $4.25 Million
15,091 Added 304.07%
20,054 $4.86 Million
Q2 2023

Aug 02, 2023

BUY
$187.26 - $240.17 $275,833 - $353,770
1,473 Added 42.21%
4,963 $1.19 Million
Q1 2023

Jun 13, 2024

SELL
$174.31 - $239.52 $38,348 - $52,694
-220 Reduced 4.68%
4,481 $842,000
Q4 2022

Feb 01, 2023

BUY
$153.06 - $226.57 $64,438 - $95,385
421 Added 13.72%
3,490 $741,000
Q3 2022

Nov 10, 2022

SELL
$145.13 - $182.49 $41,216 - $51,827
-284 Reduced 8.47%
3,069 $499,000
Q2 2022

Aug 11, 2022

BUY
$130.2 - $168.03 $3,515 - $4,536
27 Added 0.81%
3,353 $518,000
Q1 2022

May 12, 2022

SELL
$138.87 - $214.31 $216,776 - $334,537
-1,561 Reduced 31.94%
3,326 $552,000
Q4 2021

Feb 11, 2022

SELL
$182.74 - $227.9 $6.12 Million - $7.63 Million
-33,478 Reduced 87.26%
4,887 $1.08 Million
Q3 2021

Nov 12, 2021

SELL
$170.18 - $198.21 $200,642 - $233,689
-1,179 Reduced 2.98%
38,365 $7.22 Million
Q2 2021

Aug 12, 2021

BUY
$158.62 - $194.3 $6.27 Million - $7.68 Million
39,544 New
39,544 $7.17 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.